945217-70-9

Basic information

• Product Name: (4Z)-4-[(dimethylamino)methylene]-1-tritylpyrrolidine-3-one
• Synonyms: (4Z)-4-[(dimethylamino)methylene]-1-tritylpyrrolidine-3-one
• CAS NO: 945217-70-9
• Molecular Weight: 382.505
• Mol File: 945217-70-9.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: (4Z)-4-[(dimethylamino)methylene]-1-tritylpyrrolidine-3-one(CAS DataBase Reference)
• NIST Chemistry Reference: (4Z)-4-[(dimethylamino)methylene]-1-tritylpyrrolidine-3-one(945217-70-9)
• EPA Substance Registry System: (4Z)-4-[(dimethylamino)methylene]-1-tritylpyrrolidine-3-one(945217-70-9)

Safety Data

• Hazardous Substances Data: 945217-70-9(Hazardous Substances Data)

Upstream product

• 916059-16-0 1-tritylpyrrolidin-3-one 
• 4637-24-5 N,N-dimethyl-formamide dimethyl acetal 
• 916059-36-4 (R)-1-triphenylmethyl-3-pyrrolidinol 

Downstream Products

• 53493-80-4 6,7-dihydro-5H-pyrrolo[3,4-d]pyrimidine 
• 916059-34-2 benzyl [(1S,2R,5S)-5-[2-(methoxy)-5,7-dihydro-6H-pyrrolo[3,4-d]pyrimidin-6-yl]-2-(2,4,5-triflurophenyl)cyclohexyl]carbamate 
• 916059-21-7 benzyl [(1S,2R,5S)-5-[2-(methylthio)-5,7-dihydro-6H-pyrrolo[3,4-d]pyrimidin-6-yl]-2-(2,4,5-triflurophenyl)cyclohexyl]carbamate 
• 916059-22-8 benzyl [(1S,2R,5S)-5-[2-(methylsulfonyl)-5,7-dihydro-6H-pyrrolo[3,4-d]pyrimidin-6-yl]-2-(2,4,5-triflurophenyl)cyclohexyl]carbamate 
• 916059-33-1 benzyl [(1S,2R,5S)-5-[2-(2-fluoroethoxy)-5,7-dihydro-6H-pyrrolo[3,4-d]pyrimidin-6-yl]-2-(2,4,5-triflurophenyl)cyclohexyl]carbamate 
• 951127-33-6 1-methyl-5-trityl-1,4,5,6-tetrahydropyrrolo[3,4-c]pyrazole 

Relevant articles and documents

AMINOCYCLOHEXANES AS DIPEPTIDYL PEPTIDASE-IV INHIBITORS FOR THE TREATMENT OR PREVENTION OF DIABETES

The present invention is directed to novel substituted aminocyclohexanes which are inhibitors of the dipeptidyl peptidase-IV enzyme (""DPP-IV inhibitors"") and which are useful in the treatment or prevention of diseases in which the dipeptidyl peptidase-IV enzyme is involved, such as diabetes and particularly Type 2 diabetes. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which the dipeptidyl peptidase-IV enzyme is involved.